National Institute for Clinical Excellence (NICE)
MidCity Place
71 High Holborn
London
WC1V 6NA
United Kingdom
Tel: 44-0-20-7067-5800
Fax: 44-0-20-7067-5801
Website: http://www.nice.org.uk/
Email: nice@nice.nhs.uk
169 articles about National Institute for Clinical Excellence (NICE)
-
Olympus Medical Systems Corp. Plasma Prostate Resection System Is Recommended By National Institute for Clinical Excellence (NICE)
3/30/2016
-
National Institute for Clinical Excellence (NICE) Okays Medtronic Veo System for Certain Type 1 Diabetics
2/12/2016
-
Bristol-Myers Squibb Release: National Institute for Clinical Excellence (NICE) Recommends Daklinza (Daclatasvir) For Treatment Of Certain Patients With Chronic Hepatitis C Genotypes 1, 3 And 4
10/16/2015
-
Boehringer Ingelheim Release: National Institute for Clinical Excellence (NICE) Recommends VARGATEF (Nintedanib*) In Combination With Docetaxel As An Option For Patients With Non-Small Cell Lung Cancer Of Adenocarcinoma Histology Within Its Licensed Indic
6/3/2015
-
National Institute for Clinical Excellence (NICE) Plans To Recommend A Technology To Hold Catheters In Place And Reduce Infection Risk
4/2/2015
-
National Institute for Clinical Excellence (NICE) Recommends Olympus Medical's Transurethral Resection In Saline (Turis) System As The New Gold Standard For Transurethral Resection Of The Prostate (TURP)
2/25/2015
-
National Institute for Clinical Excellence (NICE) Reverses October Decision And Approves Roche's Oncology Drug Gazyvaro
12/3/2014
-
Alexion Pharmaceuticals Inc. Release: National Institute for Clinical Excellence (NICE) Issues Final Positive Recommendation For National Commissioning Of Soliris® (Eculizumab) For All Patients With aHUS In England
12/1/2014
-
National Institute for Clinical Excellence (NICE) Requests More Info On Novartis AG's Xolair To Treat Chronic Hives
11/20/2014
-
UPDATE - Avita Medical Provides National Institute for Clinical Excellence (NICE) Guidance Recommendation Update
11/13/2014
-
Onxeo Reaches Second Milestone Of BPIFrance Grant Dedicated To Livatag® Development As Part Of National Institute for Clinical Excellence (NICE) Consortium
10/13/2014
-
National Institute for Clinical Excellence (NICE) Rejects Another Roche Leukemia Drug Citing Data Uncertainties
10/6/2014
-
National Institute for Clinical Excellence (NICE) Rejects Celgene's Abraxane For Pancreatic Cancer Over Limited Benefits, Cost
9/9/2014
-
National Institute for Clinical Excellence (NICE) Recommends Commissioning Of Eculizumab (Soliris®) For All Patients With aHUS In England
9/4/2014
-
Another Controversial High Price Med: NICE Rejects Roche's New $152,850 Breast Cancer Drug
8/11/2014
-
Daiichi Sankyo, Inc. And Eli Lilly and Company: Heart Patients In England And Wales Offered More Choice Of Therapies As National Institute for Clinical Excellence (NICE) Extends Recommendations For Prasugrel
7/23/2014
-
BioTie Therapies Corp.: Selincro Receives Positive Draft Guidance From UK's National Institute for Clinical Excellence (NICE)
7/10/2014
-
Sucampo Pharmaceuticals, Inc. Release: AMITIZA® (Lubiprostone) Receives National Institute for Clinical Excellence (NICE) Recommendation
6/18/2014
-
Genzyme Corporation’s Lemtrada Recommended For Reimbursement On NHS By National Institute for Clinical Excellence (NICE)
5/28/2014
-
Genzyme Corporation's Lemtrada Recommended For Reimbursement On NHS By The National Institute for Clinical Excellence (NICE)
5/28/2014